Sign in
4

Changes in Ownership

Grace Therapeutics, Inc. Filed Acc 0000950170-23-071875

Options or other derivatives

  • Chief Executive Officer acquired 41,668 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kohli Prashant Chief Executive Officer 2023-12-19 Grant or award · Stock Options (Right to Buy) +41,668 41,668 D
Loading xslF345X05/ownership.xml…